News & Perspective

Dec 28, 2012

Dec 28, 2012

Flu markers keep climbing in US and Europe

Editor's Note: The fourth paragraph was revised on Jan 2 to clarify the current situation regarding H3N2 dominance.

(CIDRAP News) – US influenza activity continued its ascent last week, judging from the high volumes of patients seeking care for the disease at doctors' offices, while flu indicators in Europe showed a clear spike, according to the latest surveillance reports.

Nov 20, 2012

Nov 20, 2012

Sequencing supports novel coronavirus's tie to bat strains

(CIDRAP News) – Complete genetic sequencing of a novel coronavrius isolated from a Saudi Arabian man who died in June supports earlier findings that the virus is most closely related to coronaviruses found in bats, according to a report published today in mBio.

Sep 20, 2012

Sep 20, 2012

ECDC studies shed new light on narcolepsy and H1N1 vaccine

(CIDRAP News) – The European Centre for Disease Prevention and Control (ECDC) today confirmed a link between narcolepsy and pandemic 2009 H1N1 vaccination in children in Finland and Sweden, the two countries that originally reported a problem with the vaccine.

Apr 20, 2012

Apr 20, 2012

NIH endorses recommendation to publish H5N1 studies

(CIDRAP News) – The US National Institutes of Health (NIH) has endorsed the recommendations of its biosecurity advisory committee to publish the full versions of two studies describing lab-modified, mammalian-transmissible H5N1 flu viruses, NIH officials announced today.

Apr 17, 2012

Apr 17, 2012

Fouchier plans to flout Dutch export law, publish H5N1 study

(CIDRAP News) – Dutch flu researcher Ron Fouchier, PhD, said he intends to submit a revised manuscript of his controversial mutated-H5N1 study to Science without applying for an export permit, according to a Nature News story today.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»